**Eli Lilly Sees Significant Insider Buying Amid ETF Growth**
Eli Lilly (LLY), representing 16.25% of the Roundhill GLP-1 & Weight Loss ETF (OZEM), has reported notable insider buying activity, with eight directors and officers purchasing shares over the past six months. The ETF holds approximately $7.3 million in Eli Lilly shares, making it the second-largest holding in the fund. Recently, the company’s stock was trading at $1,108.09.
In total, a weighted 17.8% of OZEM’s holdings have experienced insider buying recently. Key transactions include CEO David A. Ricks buying 1,632 shares valued at over $1 million, and Director Jamere Jackson purchasing 200 shares for nearly $128,000.
